FDA.reportPublic FDA data

Trileptal 150 MG Oral Tablet

RxCUI
261356
RxNorm name
Trileptal 150 MG Oral Tablet
Display name
Trileptal 150 MG Oral Tablet
Full name
Trileptal 150 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:57

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
4c5c86c8-ab7f-4fcf-bc1b-5a0b1fd0691bTrileptal 150 MG Oral Tablet [PSN] · oxcarbazepine 150 MG Oral Tablet [Trileptal] [SBD] · Trileptal 150 MG Oral Tablet [SY]339These highlights do not include all the information needed to use TRILEPTAL safely and effectively. See full prescribing information for TRILEPTAL. TRILEPTAL ® (oxcarbazepine) film-coated tablets, for oral use TRILEPTAL ® (oxcarbazepine) oral suspension Initial U.S. Approval: 200020251216
d9741f36-0abd-49b7-9f43-e9700663122bTrileptal 150 MG Oral Tablet [PSN] · oxcarbazepine 150 MG Oral Tablet [Trileptal] [SBD] · Trileptal 150 MG Oral Tablet [SY]31These highlights do not include all the information needed to use Trileptal safely and effectively. See full prescribing information for Trileptal . Trileptal ® ( oxcarbazepine ) film-coated tablets Trileptal ® ( oxcarbazepine ) oral suspension for oral administration Initial U.S. Approval: 200020120217